“driving with dementia”的搜索结果，显示 341-350 项，共有 523 项

1. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF ... Magnetic Resonance Elastography of Dementia. Rochester, Minn. The purpose of ...

3. 轻度认知损害- 诊断与治疗- 妙佑医疗国际

   Cummings J, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimer's and Dementia. 2022; doi:10.1002/trc2.12295. Memory, forgetfulness and ...

4. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF ... Magnetic Resonance Elastography of Dementia. Rochester, Minn. The purpose of ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...

7. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

8. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease ... Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and ...

9. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...